La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Electromed a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Electromed..

Electromed (AMEX:ELMD) Azioni, Catena delle Opzioni

Electromed

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

Electromed Inc

<h3>Gainers</h3>
<ul>
<li>Traws Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRAW#NASDAQ">TRAW</a>) stock moved upwards by 139.4% to $12.02 during Monday's pre-market session. The market value of their outstanding shares is at $36.3 million. </li>
<li>GT Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTBP#NASDAQ">GTBP</a>) stock increased by 86.24% to $3.25. The company's market cap stands at $7.2 million. </li>
<li>RAPT Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) shares moved upwards by 85.3% to $1.53. The company's market cap stands at $53.4 million. </li>
<li>Phio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) stock increased by 51.7% to $2.67. The market value of their outstanding shares is at $2.8 million. </li>
<li>Ikena Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IKNA#NASDAQ">IKNA</a>) stock rose 23.22% to $1.91. The market value of their outstanding shares is at $92.1 million. </li>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) stock moved upwards by 16.63% to $0.7. The market value of their outstanding shares is at $4.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Conduit Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) shares declined by 25.6% to $0.06 during Monday's pre-market session. The company's market cap stands at $6.6 million. </li>
<li>Helius Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) stock declined by 23.08% to $0.7. The market value of their outstanding shares is at $2.6 million. </li>
<li>Psyence Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBM#NASDAQ">PBM</a>) shares declined by 18.87% to $2.58. The company's market cap stands at $2.1 million. </li>
<li>Tonix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) shares fell 15.8% to $0.52. The company's market cap stands at $96.2 million. </li>
<li>Electromed (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELMD#AMEX">ELMD</a>) shares fell 13.42% to $24.01. The market value of their outstanding shares is at $203.0 million. </li>
<li>HCW Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCWB#NASDAQ">HCWB</a>) shares declined by 13.15% to $0.39. The company's market cap stands at $17.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ELMD

GTBP

HCWB

HSDT

IKNA

PHIO

PTIX

RAPT

TNXP

TRAW

12 Health Care Stocks Moving In Monday's Pre-Market Session

Electromed (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELMD#AMEX">ELMD</a>) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.03 by 433.33 percent. This is a 700 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $14.67 million which beat the analyst consensus estimate of $13.50 million by 8.65 percent. This is a 19.02 percent increase over sales of $12.32 million the same period last year.

Earnings

Earnings Beats

News

Electromed Q1 EPS $0.16 Beats $0.03 Estimate, Sales $14.67M Beat $13.50M Estimate

ABOS

ABSI

ACNT

ACTG

AENT

AGEN

AIOT

AIRG

ALIT

ALTG

AMBC

AMPS

AMTX

APEI

AREB

ARIS

ARMN

ATRA

AUTL

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AXSM

AZTA

BHIL

BLDE

BLFS

BLTE

The Beachbody Company, Inc. Class A Common Stock

BODI

BRTX

BTMD

BTTR

BWAY

BXSL

BZFD

CAMT

CART

CATX

CAVA

CBAT

CBLL

CCLD

CGEN

CHGG

CHMI

CLSD

CNNE

CRNX

CRON

CRVS

CRWS

CVAC

CXAI

DAVA

DAVE

DRCT

DYAI

EARN

EGAN

ETON

EVCM

EVGO

EYEN

FENG

FGEN

FIHL

FLNG

FOUR

FTCI

GENI

GENK

GMGI

GOVX

GRAL

GRDN

GROV

GRPN

GRVY

Earnings Scheduled For November 12, 2024

Rumors

Analyst Ratings

Trading Ideas

Watching Electromed; Traders Circulate Stock Picked On Popular Retail Stock Trading Newsletter

Buybacks

Electromed Authorized Repurchase Of Up To $5M Of Outstanding Common Stock

WIIM

Electromed shares are trading lower after the company reported worse-than-expected Q4 revenue results.

Electromed (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELMD#AMEX">ELMD</a>) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.14 by 42.86 percent. This is a 66.67 percent increase over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $14.832 million which missed the analyst consensus estimate of $15.000 million by 1.12 percent. This is a 8.96 percent increase over sales of $13.612 million the same period last year.

Earnings Misses

Electromed Q4 2024 GAAP EPS $0.20 Beats $0.14 Estimate, Sales $14.832M Miss $15.000M Estimate

Electromed (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELMD#AMEX">ELMD</a>) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.13 by 30.77 percent. This is a 41.67 percent increase over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $13.87 million which beat the analyst consensus estimate of $13.80 million by 0.51 percent. This is a 14.94 percent increase over sales of $12.07 million the same period last year.

Electromed Q3 EPS $0.17 Beats $0.13 Estimate, Sales $13.87M Beat $13.80M Estimate

<h3>Gainers</h3>
<ul>
<li>Cogent Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COGT#NASDAQ">COGT</a>) stock increased by 64.0% to $8.96 during Wednesday's regular session. The company's market cap stands at $771.2 million. </li>
<li>Larimar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRMR#NASDAQ">LRMR</a>) shares increased by 45.53% to $12.72. The company's market cap stands at $558.4 million. </li>
<li>BioXcel Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTAI#NASDAQ">BTAI</a>) stock rose 35.2% to $3.33. The company's market cap stands at $101.0 million. </li>
<li>Greenwich LifeSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLSI#NASDAQ">GLSI</a>) stock moved upwards by 31.26% to $10.91. The company's market cap stands at $140.1 million. </li>
<li>Electromed (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELMD#AMEX">ELMD</a>) stock rose 22.61% to $12.43. The market value of their outstanding shares is at $106.6 million. As per the news, the Q2 earnings report came out yesterday. </li>
<li>Puma Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBYI#NASDAQ">PBYI</a>) shares moved upwards by 18.76% to $7.38. The market value of their outstanding shares is at $350.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Anitra (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#AMEX">AZTR</a>) stock declined by 71.3% to $0.25 during Wednesday's regular session. The market value of their outstanding shares is at $3.0 million. </li>
<li>QuidelOrtho (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QDEL#NASDAQ">QDEL</a>) stock fell 29.1% to $47.34. The company's market cap stands at $3.1 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>NeuroOne Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMTC#NASDAQ">NMTC</a>) shares decreased by 16.35% to $1.18. The company's market cap stands at $30.5 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Renalytix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNLX#NASDAQ">RNLX</a>) shares fell 14.9% to $1.2. The company's market cap stands at $59.9 million. </li>
<li>Sientra (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIEN#NASDAQ">SIEN</a>) shares declined by 14.22% to $0.17. The company's market cap stands at $2.0 million. </li>
<li>Sunshine Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFM#NASDAQ">SBFM</a>) shares declined by 12.51% to $0.06. The company's market cap stands at $1.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AZTR

BTAI

COGT

GLSI

Larimar Therapeutics, Inc. - Common Stock

LRMR

NMTC

PBYI

QDEL

RNLX

SBFM

SIEN

12 Health Care Stocks Moving In Wednesday's Intraday Session

Electromed shares are trading higher after the company reported better-than-expected Q2 results.

Electromed (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELMD#AMEX">ELMD</a>) reported its Q2 earnings results on Tuesday, February 13, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Electromed beat estimated earnings by 90.0%, reporting an EPS of $0.19 versus an estimate of $0.1.
Revenue was up $1.96 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.08 which was followed by a 2.09% increase in the share price the next day.
Here's a look at Electromed's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.10</td>
<td></td>
<td>0.10</td>
<td>0.03</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.02</td>
<td>0.12</td>
<td>0.12</td>
<td>0.11</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>12.60M</td>
<td>12.80M</td>
<td>12.05M</td>
<td>11.05M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>12.32M</td>
<td>13.61M</td>
<td>12.07M</td>
<td>11.73M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Electromed <a href="https://www.benzinga.com/quote/ELMD/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Electromed Q2 Earnings

Electromed (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELMD#AMEX">ELMD</a>) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.10 by 90 percent. This is a 72.73 percent increase over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $13.69 million which beat the analyst consensus estimate of $13.30 million by 2.92 percent. This is a 16.71 percent increase over sales of $11.73 million the same period last year.

Electromed Q2 Gaap EPS $0.19 Beats $0.10 Estimate, Sales $13.69M Beat $13.30M Estimate

ABNB

AKAM

AKTS

ALSN

ANGI

ATOM

BENF

BFAM

BIIB

BRKR

CHCT

CRSR

CTHR

DDOG

DENN

DNUT

ENTG

FELE

GCMG

GDDY

GNSS

GORO

HOOD

HYLN

INCY

INMD

INVH

IOSP

IPGP

KTOS

LCII

LDOS

LOPE

LYFT

MODG

NTWK

REZI

ROIV

RUSHA

RUSHB

SHOP

SITC

SITM

SMWB

SSNC

STAG

TYGO

UFCS

UPST

USAC

VTGN

Earnings Scheduled For February 13, 2024

Electromed (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELMD#AMEX">ELMD</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-02-13. Here's what investors need to know before the announcement.
Analysts estimate that Electromed will report an earnings per share (EPS) of $0.10. 
Electromed bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.08, which was followed by a 2.09% increase in the share price the next day.
Here's a look at Electromed's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.10</td>
<td></td>
<td>0.10</td>
<td>0.03</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.02</td>
<td>0.12</td>
<td>0.12</td>
<td>0.11</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.09%</td>
<td>10.59%</td>
<td>12.02%</td>
<td>5.68%</td>
</tr>
</tbody>
</table>

<h3>Stock Performance</h3>
Shares of Electromed were trading at $10.38 as of February 09. Over the last 52-week period, shares are down 10.97%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/ELMD/earnings">To track all earnings releases for Electromed visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Electromed

Biotech

Contracts

General

Electromed  Entered Into Distribution Agreement With Marathon Medical Corp; Financial Terms Not Disclosed

Bradley Nagel, Chief Financial Officer at Electromed (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELMD#AMEX">ELMD</a>), reported a large acquisition of company stock options on November 14, according to a new SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001488917/000143774923032054//Archives/edgar/data/1488917/000143774923032054/0001437749-23-032054-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday showed that Nagel, Chief Financial Officer at Electromed, a company in the Health Care sector, was just awarded stock options worth 6,500 shares of ELMD. The options give Nagel the right to buy the company's stock at $10.25 per share.
Electromed shares are trading down 0.0% at $10.52 at the time of this writing on Wednesday morning. Since the current price is $10.52, this makes Nagel's 6,500 shares worth $68,380.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Transaction Codes To Focus On</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001488917">Check Out The Full List Of Electromed's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Chief Financial Officer at Electromed Acquires Company Stock Options Worth 6,500 Shares

Electromed (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELMD#AMEX">ELMD</a>) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.10 by 80 percent. This is a 100 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $12.32 million which missed the analyst consensus estimate of $12.60 million by 2.19 percent. This is a 15.63 percent increase over sales of $10.66 million the same period last year.

Electromed Q1 2024 EPS $0.02 Misses $0.10 Estimate, Sales $12.32M Miss $12.60M Estimate

Electromed (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELMD#AMEX">ELMD</a>) reported quarterly earnings of $0.12 per share. This is a 200 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $13.60 million which beat the analyst consensus estimate of $12.80 million by 6.25 percent. This is a 20.70 percent increase over sales of $11.27 million the same period last year.

Electromed Q4 EPS $0.12 Up From $0.04 YoY, Sales $13.60M Beat $12.80M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; BHP Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHP#NYSE">BHP</a>) is estimated to report earnings for its Fiscal Year 2023.
&bull; Dick&#39;s Sporting Goods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) is likely to report quarterly earnings at $3.81 per share on revenue of $3.23 billion.
&bull; Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) is likely to report quarterly earnings at $2.32 per share on revenue of $4.57 billion.
&bull; MINISO Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNSO#NYSE">MNSO</a>) is estimated to report quarterly earnings at $0.22 per share on revenue of $434.37 million.
&bull; ScanSource (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCSC#NASDAQ">SCSC</a>) is projected to report quarterly earnings at $0.75 per share on revenue of $897.20 million.
&bull; Sphere Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHR#NYSE">SPHR</a>) is estimated to report quarterly loss at $0.59 per share on revenue of $129.21 million.
&bull; GDS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) is likely to report quarterly loss at $0.26 per share on revenue of $337.64 million.
&bull; Macy&#39;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) is estimated to report quarterly earnings at $0.13 per share on revenue of $5.09 billion.
&bull; Citi Trends (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTRN#NASDAQ">CTRN</a>) is estimated to report quarterly loss at $0.97 per share on revenue of $165.57 million.
&bull; BJ&#39;s Wholesale Club (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>) is projected to report quarterly earnings at $0.90 per share on revenue of $5.15 billion.
&bull; Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) is likely to report quarterly earnings at $0.02 per share on revenue of $1.31 billion.
&bull; Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) is estimated to report quarterly earnings at $0.66 per share on revenue of $356.32 million.
&bull; Kingsoft Cloud Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) is estimated to report quarterly loss at $0.20 per share on revenue of $268.15 million.
&bull; Canadian Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) is estimated to report quarterly earnings at $1.52 per share on revenue of $2.48 billion.
&bull; Lowe&#39;s Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) is estimated to report quarterly earnings at $4.49 per share on revenue of $24.99 billion.
&bull; Yatsen Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YSG#NYSE">YSG</a>) is estimated to report earnings for its second quarter.
&bull; iQIYI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IQ#NASDAQ">IQ</a>) is expected to report quarterly earnings at $0.05 per share on revenue of $1.07 billion.
&bull; Viomi Technology Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIOT#NASDAQ">VIOT</a>) is projected to report earnings for its first quarter.
&bull; BOS Better Online Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOSC#NASDAQ">BOSC</a>) is likely to report earnings for its second quarter.
&bull; Medtronic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>) is expected to report quarterly earnings at $1.11 per share on revenue of $7.57 billion.
&bull; Garmin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRMN#NYSE">GRMN</a>) is estimated to report earnings for its second quarter.
<h3>Companies Reporting After The Bell</h3>
&bull; Fidelis Insurance Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIHL#NYSE">FIHL</a>) is likely to report earnings for its second quarter.
&bull; Toll Brothers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) is likely to report quarterly earnings at $2.81 per share on revenue of $2.41 billion.
&bull; BM Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMTX#AMEX">BMTX</a>) is likely to report quarterly loss at $0.24 per share on revenue of $15.06 million.
&bull; La-Z-Boy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LZB#NYSE">LZB</a>) is projected to report quarterly earnings at $0.55 per share on revenue of $474.58 million.
&bull; Electromed (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELMD#AMEX">ELMD</a>) is likely to report earnings for its fourth quarter.
&bull; Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) is expected to report quarterly earnings at $0.89 per share on revenue of $1.25 billion.
&bull; ToughBuilt Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBLT#NASDAQ">TBLT</a>) is likely to report earnings for its second quarter.
&bull; FS Credit Opp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSCO#NYSE">FSCO</a>) is expected to report earnings for its second quarter.
&bull; Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) is expected to report earnings for its second quarter.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

BIDU

Earnings Scheduled For August 22, 2023

Comments

Electromed

Electromed (ELMD) Opzioni

Electromed (AMEX:ELMD) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO